vs
iRhythm Holdings, Inc.（IRTC）とBRC Group Holdings, Inc.（RILY）の財務データ比較。上の社名をクリックして会社を切り替えられます
iRhythm Holdings, Inc.の直近四半期売上が大きい（$208.9M vs $188.3M、BRC Group Holdings, Inc.の約1.1倍）。BRC Group Holdings, Inc.の純利益率が高く（47.9% vs 2.7%、差は45.3%）。iRhythm Holdings, Inc.の前年同期比売上増加率が高い（27.1% vs -21.9%）。過去8四半期でiRhythm Holdings, Inc.の売上複合成長率が高い（25.8% vs -15.4%）
iRhythm Holdingsは心臓ケア分野に特化したデジタルヘルスケア企業で、ウェアラブル型の携帯用心拍モニタリングデバイスとAI搭載の解析ツールを開発・販売しています。主に米国の医療機関と患者を対象に、心房細動などの不整脈の検出を支援し、臨床診断に有用なデータを提供しています。
IRTC vs RILY — 直接比較
売上が大きい
IRTC
1.1倍大きい
$188.3M
売上成長率が高い
IRTC
+49.0%の差
-21.9%
純利益率が高い
RILY
純利益率が45.3%高い
2.7%
2年売上CAGRが高い
IRTC
2年複合成長率
-15.4%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $208.9M | $188.3M |
| 純利益 | $5.6M | $90.3M |
| 粗利率 | 70.9% | 79.5% |
| 営業利益率 | 1.1% | 32.3% |
| 純利益率 | 2.7% | 47.9% |
| 売上前年比 | 27.1% | -21.9% |
| 純利益前年比 | 518.5% | 1710.8% |
| EPS（希薄化後） | $0.18 | $2.78 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上IRTCRILY
| Q4 25 | $208.9M | $188.3M | ||
| Q3 25 | $192.9M | $215.3M | ||
| Q2 25 | $186.7M | $188.2M | ||
| Q1 25 | $158.7M | $197.2M | ||
| Q4 24 | $164.3M | $241.0M | ||
| Q3 24 | $147.5M | $225.5M | ||
| Q2 24 | $148.0M | $256.0M | ||
| Q1 24 | $131.9M | $263.4M |
純利益IRTCRILY
| Q4 25 | $5.6M | $90.3M | ||
| Q3 25 | $-5.2M | $91.1M | ||
| Q2 25 | $-14.2M | $139.5M | ||
| Q1 25 | $-30.7M | $-10.0M | ||
| Q4 24 | $-1.3M | $-5.6M | ||
| Q3 24 | $-46.2M | $-284.4M | ||
| Q2 24 | $-20.1M | $-433.6M | ||
| Q1 24 | $-45.7M | $-49.2M |
粗利率IRTCRILY
| Q4 25 | 70.9% | 79.5% | ||
| Q3 25 | 71.1% | 83.7% | ||
| Q2 25 | 71.2% | 81.3% | ||
| Q1 25 | 68.8% | 81.4% | ||
| Q4 24 | 70.0% | 79.8% | ||
| Q3 24 | 68.8% | 82.1% | ||
| Q2 24 | 69.9% | 84.5% | ||
| Q1 24 | 66.3% | 85.3% |
営業利益率IRTCRILY
| Q4 25 | 1.1% | 32.3% | ||
| Q3 25 | -4.4% | 30.4% | ||
| Q2 25 | -10.0% | 5.7% | ||
| Q1 25 | -20.5% | -31.2% | ||
| Q4 24 | -2.5% | -69.2% | ||
| Q3 24 | -34.1% | -36.4% | ||
| Q2 24 | -15.5% | -90.8% | ||
| Q1 24 | -28.9% | -6.1% |
純利益率IRTCRILY
| Q4 25 | 2.7% | 47.9% | ||
| Q3 25 | -2.7% | 42.3% | ||
| Q2 25 | -7.6% | 74.1% | ||
| Q1 25 | -19.3% | -5.1% | ||
| Q4 24 | -0.8% | -2.3% | ||
| Q3 24 | -31.3% | -126.1% | ||
| Q2 24 | -13.6% | -169.4% | ||
| Q1 24 | -34.6% | -18.7% |
EPS（希薄化後）IRTCRILY
| Q4 25 | $0.18 | $2.78 | ||
| Q3 25 | $-0.16 | $2.91 | ||
| Q2 25 | $-0.44 | $4.50 | ||
| Q1 25 | $-0.97 | $-0.39 | ||
| Q4 24 | $-0.03 | $-0.01 | ||
| Q3 24 | $-1.48 | $-9.39 | ||
| Q2 24 | $-0.65 | $-14.35 | ||
| Q1 24 | $-1.47 | $-1.71 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $583.8M | $226.6M |
| 総負債低いほど良い | — | $1.4B |
| 株主資本純資産 | $152.7M | $-171.5M |
| 総資産 | $1.0B | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資IRTCRILY
| Q4 25 | $583.8M | $226.6M | ||
| Q3 25 | $565.2M | $184.2M | ||
| Q2 25 | $545.5M | $267.4M | ||
| Q1 25 | $520.6M | $138.3M | ||
| Q4 24 | $535.6M | $146.9M | ||
| Q3 24 | $522.0M | $159.2M | ||
| Q2 24 | $561.5M | $236.9M | ||
| Q1 24 | $569.1M | $190.7M |
総負債IRTCRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
株主資本IRTCRILY
| Q4 25 | $152.7M | $-171.5M | ||
| Q3 25 | $121.9M | $-260.5M | ||
| Q2 25 | $103.7M | $-351.7M | ||
| Q1 25 | $86.7M | $-496.8M | ||
| Q4 24 | $90.9M | $-488.2M | ||
| Q3 24 | $71.8M | $-497.6M | ||
| Q2 24 | $99.2M | $-218.3M | ||
| Q1 24 | $90.3M | $228.4M |
総資産IRTCRILY
| Q4 25 | $1.0B | $1.7B | ||
| Q3 25 | $995.2M | $1.7B | ||
| Q2 25 | $964.0M | $1.5B | ||
| Q1 25 | $926.1M | $1.5B | ||
| Q4 24 | $931.4M | $1.8B | ||
| Q3 24 | $909.7M | $2.2B | ||
| Q2 24 | $919.2M | $3.2B | ||
| Q1 24 | $909.8M | $5.0B |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $26.2M | $26.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $14.5M | — |
| FCFマージンFCF / 売上 | 6.9% | — |
| 設備投資強度設備投資 / 売上 | 5.6% | — |
| キャッシュ転換率営業CF / 純利益 | 4.70× | 0.29× |
| 直近12ヶ月FCF直近4四半期 | $34.5M | — |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローIRTCRILY
| Q4 25 | $26.2M | $26.2M | ||
| Q3 25 | $34.9M | $-60.6M | ||
| Q2 25 | $27.7M | $-25.6M | ||
| Q1 25 | $-7.9M | $184.0K | ||
| Q4 24 | $19.2M | $-2.7M | ||
| Q3 24 | $24.3M | $19.5M | ||
| Q2 24 | $11.8M | $111.5M | ||
| Q1 24 | $-52.0M | $135.4M |
フリーキャッシュフローIRTCRILY
| Q4 25 | $14.5M | — | ||
| Q3 25 | $20.1M | — | ||
| Q2 25 | $17.3M | — | ||
| Q1 25 | $-17.3M | — | ||
| Q4 24 | $12.4M | — | ||
| Q3 24 | $15.5M | — | ||
| Q2 24 | $3.4M | — | ||
| Q1 24 | $-61.8M | — |
FCFマージンIRTCRILY
| Q4 25 | 6.9% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | -10.9% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | -46.8% | — |
設備投資強度IRTCRILY
| Q4 25 | 5.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 5.9% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 5.7% | — | ||
| Q1 24 | 7.4% | — |
キャッシュ転換率IRTCRILY
| Q4 25 | 4.70× | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
